Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework-Reference-Cited by-同舟云学术

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

Published:2018-09-22 Issue:1 Volume:39 Page:20-30
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Day Emma¹^ORCID,Hellard Margaret²^ORCID,Treloar Carla³,Bruneau Julie⁴,Martin Natasha K.⁵,Øvrehus Anne⁶,Dalgard Olav⁷^ORCID,Lloyd Andrew⁸,Dillon John⁹^ORCID,Hickman Matt¹⁰^ORCID,Byrne Jude¹¹,Litwin Alain¹²,Maticic Mojca¹³¹⁴,Bruggmann Philip¹⁵^ORCID,Midgard Havard¹⁶,Norton Brianna¹²,Trooskin Stacey¹⁷,Lazarus Jeffrey V.¹⁸^ORCID,Grebely Jason⁸^ORCID,

Affiliation:

1. Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine; Sydney New South Wales Australia

2. Disease Elimination Program; Burnet Institute; Melbourne Victoria Australia

3. Centre for Social Research in Health; UNSW Sydney; Sydney New South Wales Australia

4. CHUM Research Centre (CRCHUM); Centre Hospitalier de l'Université de Montréal; Montréal Quebec Canada

5. Division of Global Public Health; University of California; San Diego California

6. Department of Infectious Diseases; Odense University Hospital; Odense Denmark

7. Department of Infectious Diseases; Institute of Clinical Medicine; Akershus University Hospital; University of Oslo; Oslo Norway

8. The Kirby Institute; UNSW Sydney; Sydney New South Wales Australia

9. Division of Molecular and Clinical Medicine; School of Medicine; University of Dundee; Dundee UK

10. Population Health Sciences; Bristol Medical School; University of Bristol; Bristol UK

11. Australian Injecting & Illicit Drug Users League; Canberra Australian Capital Territory Australia

12. University of South Carolina School of Medicine Greenville; Greenville South Carolina

13. Clinic for Infectious Diseases and Febrile Illnesses; University Medical Centre Ljubljana; Ljubljana Slovenia

14. Faculty of Medicine; University of Ljubljana; Ljubljana Slovenia

15. Arud Centres for Addiction Medicine; Zürich Switzerland

16. Department of Gastroenterology; Institute of Clinical Medicine; Oslo University Hospital; University of Oslo; Oslo Norway

17. Philadelphia FIGHT; Philadelphia Pennsylvania

18. Barcelona Institute for Global Health (ISGlobal); Hospital Clínic; University of Barcelona; Barcelona Spain

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13949/fullpdf

Reference134 articles.

1. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;The Polaris Observatory HCV Collaborators;Lancet Gastroenterol Hepatol,2017

3. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

4. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review;Falade-Nwulia;Ann Intern Med,2017

5. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review;Degenhardt;Lancet Glob Health,2017

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs;Drug and Alcohol Dependence Reports;2024-03

2. Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study;Health Science Reports;2024-01

3. Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study;The Lancet Regional Health - Americas;2024-01

4. Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial;Clinical Infectious Diseases;2023-11-22

5. Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate Hepatitis C Australia Outreach Project, 2020–2022;BMC Public Health;2023-11-20